Tufts researchers have developed neurotransmitter-lipid hybrids that help transport therapeutic drugs and gene editing proteins across the blood-brain barrier in mice.
A new study reports researchers have successfully modified a virus to be able to enter a mouse brain via the bloodstream and deliver genes to central nervous system cells.
